データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
Is AbCellera Biologics (NASDAQ:ABCL) In A Good Position To Invest In Growth?
Watching AbCellera Biologics; Shares See Volume To The Upside, Traders Circulate Ray Blancos Catalyst Trader Action Alert To Buy The Stock Up To $4
Stocks With Improving and Deteriorating 'TechniGrade' by Piper Sandler
Individual Investors Who Own 34% Along With Institutions Invested in AbCellera Biologics Inc. (NASDAQ:ABCL) Saw Increase in Their Holdings Value Last Week
AbCellera to Present at Upcoming Investor Conferences in December and January
AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024